Latin America Over The Counter (OTC) Drugs Market, 2012-2023

January 2018 | 205 pages | ID: LEE386C0F12EN
Precision Business Insights (PBI)

Abstracts

Latin America Over The Counter (OTC) Drugs Market

Over-the-counter (OTC) drugs Market, also known as the non-prescription drugs that can be bought without a prescription. Over-the-counter drugs are safe and effective when the consumer follows the directions on the label or as provided by a physician. Over-the-counter (OTC) drugs are primarily used to treat conditions that do not require direct consultation of a doctor. Over-the-counter drugs provide affordable treatment and also help to decrease the workload of physicians. Over-the-counter drugs are easily available in pharmacies. Even though these products are considered as over-the-counter because these are not directly kept on pharmacy counters and must be dispensed by a pharmacist after confirming age, identity, and patient knowledge regarding usage of the product.

Latin America (OTC) drugs market is growing at a significant CAGR due to rise in the population. Increase in the adoption of western lifestyles, promotion and marketing initiatives for over-the-counter products, the rise in the healthcare expenditure, and an increase in the geriatric population expected to fuel the Latin America Over The Counter Drugs Market over the forecast period. Furthermore, rise in demand for self-medication with non-prescription drugs, changes in cultural attitudes regarding self-medications required for minor health problems, convenience in the direct purchase, savings enabled by the use of over-the-counter drugs, and developments and innovations in drugs products expected to fuel the Latin-America over-the-counter drugs market. However, competition between the existing market players, more possibilities of substance addiction and abuse, severity and complications involved in the taking of wrong medications due to misdiagnosis and lack of awareness among the rural population in developing and underdeveloped countries might hinder the Latin America over-the-counter drugs market over the forecast period.

The Latin America Over The Counter Drugs Market is segmented on the basis of product type, formulation type, and distribution channel

Based on product type, Latin America Over The Counter Drugs Market has been segmented into the following:

• Pain Products
• Cough, Cold and Flu Products
• Vitamins and Minerals
• Gastrointestinal Products
• Ophthalmic Products
• Sleep Aid Products
• Weight Loss/Diet Products
• Others

Based on formulation type, Latin America Over The Counter Drugs Market has been segmented into the following:

• Tablets
• Liquids
• Ointments
• Sprays
• Others

Based on distribution channel, Latin America Over The Counter Drugs Market has been segmented into the following:

• Pharmacies
• Supermarkets/Hypermarkets
• Convenience stores
• Online drugstores
• Others

The Latin America Over The Counter Drugs Market is in the flourishing stage with several local and international players actively engaged in the launch of new products to increase their market share in the Latin America over-the-counter drugs market. Some of the key strategies followed by various pharmaceutical companies include acquisitions and mergers, collaborations, and technological innovations for over-the-counter drugs. For instance, in February 2013, Reckitt Benckiser, the manufacturer of Nurofen painkillers, paid to Bristol-Myers Squibb about US$ 482 Mn to license a portfolio of Latin American over-the-counter healthcare products. Moreover, in December 2016, Perrigo Company plc received FDA approval for Nicorette over the product and the company plans to launch the product in various countries including Latin America.

Geographically, Latin America Over The Counter Drugs Market segmented into the following countries such as Brazil, Mexico, Chile, Argentina, Venezuela and Rest of Latin America as these are the largest pharmaceutical markets in the region. Brazil holds the largest share, which is attributed to highest population among all Latin American countries, increase in awareness regarding the over-the-counter drugs. OTC drugs such as analgesics and contraceptives are commonly used in the Brazil. In Argentina, it is very common that a citizen can buy antibiotics without a prescription. Increase in population, advertising and marketing regarding the over-the-counter drugs, and ease of availability of over-the-counter drugs expected to fuel the Latin America over-the-counter drugs market over the forecast period.

Some of the players in Latin America Over The Counter Drugs Market are Novartis AG (Switzerland), Pfizer, Inc. (U.S.), Valeant (Canada), Perrigo Company plc. (U.S.), Sanofi-Aventis (France), GlaxoSmithKline plc. (U.K.), Johnson & Johnson Services, Inc. (U.S.), Bayer AG (Germany), Takeda Pharmaceuticals company Ltd. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Bristol-Myers Squibb (U.S.), and Reckitt Benckiser Group plc (U.K.) to name a few.

In September 2017, Isodiol International Inc. planned to launch OTC products in the Latin America region

In May 2014, Bayer acquired the consumer care business of Merck & Co., Inc., in Latin America and North America regions

Contents

1. EXECUTIVE SUMMARY

2. LATIN AMERICA OVER THE COUNTER (OTC) MARKET INTRODUCTION

2.1. Latin America Over The Counter (OTC) Market – Taxonomy
2.2. Latin America Over The Counter (OTC) Market –Definitions
  2.2.1. Product Type
  2.2.2. Formulation Type
  2.2.3. Distribution Channel

3. LATIN AMERICA OVER THE COUNTER (OTC) MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Latin America Over The Counter (OTC) Market Dynamics – Factors Impact Analysis
3.6. Latin America Over The Counter (OTC) Market – Regulations
3.7. Latin America Over The Counter (OTC) Market – Product Innovations

4. LATIN AMERICA OVER THE COUNTER (OTC) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. LATIN AMERICA OVER THE COUNTER (OTC) MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Pain Products
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.1.3. Market Opportunity Analysis
5.2. Cough, Cold and Flu Products
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.2.3. Market Opportunity Analysis
5.3. Vitamins and Minerals
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.3.3. Market Opportunity Analysis
5.4. Gastrointestinal Products
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.4.3. Market Opportunity Analysis
5.5. Ophthalmic Products
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.5.3. Market Opportunity Analysis
5.6. Sleep Aid Products
  5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.6.3. Market Opportunity Analysis
5.7. Weight Loss/Diet Products
  5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.7.3. Market Opportunity Analysis
5.8. Others
  5.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.8.3. Market Opportunity Analysis

6. LATIN AMERICA OVER THE COUNTER (OTC) MARKET FORECAST, BY FORMULATION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Tablets
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.1.3. Market Opportunity Analysis
6.2. Liquids
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.2.3. Market Opportunity Analysis
6.3. Ointments
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.3.3. Market Opportunity Analysis
6.4. Sprays
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.4.3. Market Opportunity Analysis
6.5. Others
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.5.3. Market Opportunity Analysis

7. LATIN AMERICA OVER THE COUNTER (OTC) MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Pharmacies
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.1.3. Market Opportunity Analysis
7.2. Supermarkets/Hypermarkets
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.2.3. Market Opportunity Analysis
7.3. Convenience stores
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.3.3. Market Opportunity Analysis
7.4. Online drugstores
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.4.3. Market Opportunity Analysis
7.5. Others
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.5.3. Market Opportunity Analysis

8. ARGENTINA OVER THE COUNTER (OTC) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.1.1. Pain Products
  8.1.2. Cough, Cold and Flu Products
  8.1.3. Vitamins and Minerals
  8.1.4. Gastrointestinal Products
  8.1.5. Ophthalmic Products
  8.1.6. Sleep Aid Products
  8.1.7. Weight Loss/Diet Products
  8.1.8. Others
8.2. Formulation Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  8.2.1. Tablets
  8.2.2. Liquids
  8.2.3. Ointments
  8.2.4. Sprays
  8.2.5. Others
8.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  8.3.1. Pharmacies
  8.3.2. Supermarkets/Hypermarkets
  8.3.3. Convenience stores
  8.3.4. Online drugstores
  8.3.5. Others
8.4. Argentina Over The Counter (OTC) Market - Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2017 – 2023
8.5. Argentina Over The Counter (OTC) Market Dynamics – Trends

9. BRAZIL OVER THE COUNTER (OTC) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Pain Products
  9.1.2. Cough, Cold and Flu Products
  9.1.3. Vitamins and Minerals
  9.1.4. Gastrointestinal Products
  9.1.5. Ophthalmic Products
  9.1.6. Sleep Aid Products
  9.1.7. Weight Loss/Diet Products
  9.1.8. Others
9.2. Formulation Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.2.1. Tablets
  9.2.2. Liquids
  9.2.3. Ointments
  9.2.4. Sprays
  9.2.5. Others
9.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Pharmacies
  9.3.2. Supermarkets/Hypermarkets
  9.3.3. Convenience stores
  9.3.4. Online drugstores
  9.3.5. Others
9.4. Brazil Over The Counter (OTC) Market - Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2017 – 2023
9.5. 9.4. Brazil Over The Counter (OTC) Market Dynamics – Trends

10. MEXICO OVER THE COUNTER (OTC) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Pain Products
  10.1.2. Cough, Cold and Flu Products
  10.1.3. Vitamins and Minerals
  10.1.4. Gastrointestinal Products
  10.1.5. Ophthalmic Products
  10.1.6. Sleep Aid Products
  10.1.7. Weight Loss/Diet Products
  10.1.8. Others
10.2. Formulation Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. Tablets
  10.2.2. Liquids
  10.2.3. Ointments
  10.2.4. Sprays
  10.2.5. Others
10.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Pharmacies
  10.3.2. Supermarkets/Hypermarkets
  10.3.3. Convenience stores
  10.3.4. Online drugstores
  10.3.5. Others
10.4. Mexico Over The Counter (OTC) Market - Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2017 – 2023
10.5. 9.4. Mexico Over The Counter (OTC) Market Dynamics – Trends

11. REST OF LATIN AMERICA OVER THE COUNTER (OTC) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Pain Products
  11.1.2. Cough, Cold and Flu Products
  11.1.3. Vitamins and Minerals
  11.1.4. Gastrointestinal Products
  11.1.5. Ophthalmic Products
  11.1.6. Sleep Aid Products
  11.1.7. Weight Loss/Diet Products
  11.1.8. Others
11.2. Formulation Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. Tablets
  11.2.2. Liquids
  11.2.3. Ointments
  11.2.4. Sprays
  11.2.5. Others
11.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Pharmacies
  11.3.2. Supermarkets/Hypermarkets
  11.3.3. Convenience stores
  11.3.4. Online drugstores
  11.3.5. Others
11.4. Rest of Latin America Over The Counter (OTC) Market - Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2017 – 2023
11.5. 9.4. Rest of Latin America Over The Counter (OTC) Market Dynamics – Trends

12. COMPETITION LANDSCAPE

12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  12.2.1. Novartis AG (Switzerland)
  12.2.2. Pfizer, Inc. (U.S.)
  12.2.3. Valeant (Canada)
  12.2.4. Perrigo Company plc. (U.S.)
  12.2.5. Sanofi (France)
  12.2.6. GlaxoSmithKline plc. (U.K.)
  12.2.7. Johnson & Johnson Services, Inc. (U.S.)
  12.2.8. Bayer AG (Germany)
  12.2.9. Takeda Pharmaceuticals company Ltd. (Japan)
  12.2.10. Teva Pharmaceutical Industries Ltd. (Israel)
  12.2.11. Bristol-Myers Squibb (U.S.)
  12.2.12. Reckitt Benckiser Group plc (U.K.)

13. RESEARCH METHODOLOGY

14. KEY ASSUMPTIONS AND ACRONYMS